Sensus Healthcare Dirección
Dirección controles de criterios 4/4
El CEO de Sensus Healthcare's es Joe Sardano , nombrado en Jun 2010, tiene una permanencia de 13.83 años. compensación anual total es $754.43K, compuesta por 53% salario y 47% primas, incluidas acciones y opciones de la empresa. posee directamente un 7.17% de las acciones de la empresa, por valor de $3.91M. La antigüedad media del equipo directivo y de la junta directiva es de 2.8 años y 11.4 años, respectivamente.
Información clave
Joe Sardano
Chief Executive Officer (CEO)
US$687.6k
Compensación total
| Porcentaje del salario del CEO | 65.4% |
| Permanencia del CEO | 13.9yrs |
| Participación del CEO | 7.2% |
| Permanencia media de la dirección | 2.8yrs |
| Promedio de permanencia en la Junta Directiva | 7.6yrs |
Actualizaciones recientes de la dirección
Recent updates
Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16
Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Sensus Healthcare Q2 GAAP EPS, revenue beats
Aug 04Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
May 21Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts
May 11Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist
Apr 29Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality
Apr 01Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?
Dec 17We Discuss Why Sensus Healthcare, Inc.'s (NASDAQ:SRTS) CEO Compensation May Be Closely Reviewed
May 30Sensus Healthcare: Likely Post-Pandemic Sales Recovery Can Boost Share Price
Apr 26Analysts Expect Breakeven For Sensus Healthcare, Inc. (NASDAQ:SRTS) Before Long
Apr 19Sensus Healthcare's (NASDAQ:SRTS) Stock Price Has Reduced 30% In The Past Three Years
Feb 23Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$688k | US$450k | US$485k |
| Sep 30 2023 | n/a | n/a | -US$896k |
| Jun 30 2023 | n/a | n/a | US$2m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$754k | US$400k | US$24m |
| Sep 30 2022 | n/a | n/a | US$27m |
| Jun 30 2022 | n/a | n/a | US$25m |
| Mar 31 2022 | n/a | n/a | US$21m |
| Dec 31 2021 | US$628k | US$375k | US$4m |
| Sep 30 2021 | n/a | n/a | -US$181k |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$510k | US$375k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$3m |
| Dec 31 2019 | US$467k | US$375k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$3m |
| Dec 31 2018 | US$538k | US$360k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$3m |
| Jun 30 2018 | n/a | n/a | -US$3m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$490k | US$324k | -US$4m |
Compensación vs. Mercado: La compensación total ($USD754.43K) de Joe está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de Joe ha sido consistente con los resultados de la empresa en el último año.
CEO
Joe Sardano (70 yo)
13.9yrs
Permanencia
US$687,599
Compensación
Mr. Joseph C. Sardano, also known as Joe, serves as Director at BioFlorida Inc since August 2021. He Co-Founded Sensus Healthcare, Inc. in 2010 and has been its Chairman of the Board, Chief Executive Offic...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 13.9yrs | US$687.60k | 7.17% $ 4.5m | |
| President | 7.3yrs | US$452.53k | 0.48% $ 300.1k | |
| Chief Financial Officer | 4.3yrs | US$357.06k | 0.27% $ 168.3k | |
| Chief Operating Officer | 1.3yrs | sin datos | 0.060% $ 37.2k | |
| Chief Technology Officer | 1.3yrs | sin datos | 0.061% $ 38.1k | |
| Vice President of Marketing | 1.3yrs | sin datos | sin datos |
2.8yrs
Permanencia media
45yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de SRTS se considera experimentado (2.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 13.9yrs | US$687.60k | 7.17% $ 4.5m | |
| President | less than a year | US$452.53k | 0.48% $ 300.1k | |
| Independent Director | 7.8yrs | US$75.00k | 0.28% $ 177.0k | |
| Independent Director | 12.3yrs | US$75.00k | 0.49% $ 304.6k | |
| Member of Medical Advisory Board | 7.3yrs | sin datos | sin datos | |
| Independent Director | 12.3yrs | US$75.00k | 0.88% $ 547.0k | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | 7.3yrs | sin datos | sin datos | |
| Member of Medical Advisory Board | 7.3yrs | sin datos | sin datos | |
| Independent Director | 8.6yrs | US$75.00k | 0.061% $ 38.1k | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | 6.5yrs | sin datos | sin datos |
7.6yrs
Permanencia media
70yo
Promedio de edad
Junta con experiencia: La junta directiva de SRTS se considera experimentada (7.6 años de antigüedad promedio).